FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

10685011000001109: Sorafenib 200mg tablets 112 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
36906401000001117 Sorafenib 200mg tablets 112 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
36906501000001118 Sorafenib 200mg tablets 112 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

5 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sorafenib 200mg tablets 112 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sorafenib 200mg tablets 112 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Sorafenib 200mg tablets 112 tablet Is pack of Product containing precisely sorafenib (as sorafenib tosylate) 200 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Sorafenib 200mg tablets 112 tablet Has active ingredient Sorafenib tosylate false Inferred relationship Existential restriction modifier
Sorafenib 200mg tablets 112 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Sorafenib 200mg tablets 112 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sorafenib 200mg tablets 112 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sorafenib 200mg tablets 112 tablet Has active ingredient Sorafenib tosylate false Inferred relationship Existential restriction modifier
Sorafenib 200mg tablets 112 tablet Has VMP Product containing precisely sorafenib (as sorafenib tosylate) 200 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Sorafenib 200mg tablets 112 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Sorafenib true Inferred relationship Existential restriction modifier
Sorafenib 200mg tablets 112 tablet Has specific active ingredient Sorafenib tosylate true Inferred relationship Existential restriction modifier
Sorafenib 200mg tablets 112 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Sorafenib 200mg tablets 112 tablet Has basis of strength substance Sorafenib true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Sorafenib 200mg tablets (Sandoz Ltd) 112 tablet 4 x 28 tablets Is a True Sorafenib 200mg tablets 112 tablet Inferred relationship Existential restriction modifier
Sorafenib 200mg tablets (Teva UK Ltd) 112 tablet 8 x 14 tablets Is a True Sorafenib 200mg tablets 112 tablet Inferred relationship Existential restriction modifier
Sorafenib 200mg tablets (Zentiva Pharma UK Ltd) 112 tablet 4 x 28 tablets Is a True Sorafenib 200mg tablets 112 tablet Inferred relationship Existential restriction modifier
Nexavar 200mg tablets (Bayer Plc) 112 tablet 4 x 28 tablets Is a True Sorafenib 200mg tablets 112 tablet Inferred relationship Existential restriction modifier
Nexavar 200mg tablets (Originalis B.V.) 112 tablet Is a True Sorafenib 200mg tablets 112 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start